title: The North Carolina contribution to the CAPRISA 004 study: the Global Health Initiative in action.
authors.affiliation: FHI. wcates@fhi.org
authors.forename: Willard
authors.initials: W
authors.lastname: Cates
authors.forename: Angela D M
authors.initials: AD
authors.lastname: Kashuba
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000282:Administration, Intravaginal; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D005260:Female; D014943:Global Health; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D007373:Interinstitutional Relations; D009657:North Carolina; D063065:Organophosphonates / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D013019:South Africa; D000068698:Tenofovir; D014495:Universities
chemical_list: D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine